Pfizer is planning to test a daily weight-loss pill in mid-stage trials later this year, as the struggling pharmaceutical group pins its hope on the experimental drug as its route into a market projected to be worth more than $130bn a year.
輝瑞(Pfizer)正計劃在今年晚些時候對一種日用減肥藥進行中期試驗，這家陷入困境的製藥集團寄希望於將這種試驗性藥物作爲其進入一個預計每年價值超過1300億美元的市場的途徑。
您已閱讀8%（327字），剩餘92%（3800字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。